ÇÁ·Î¼¼½º, ¾àÁ¦ À¯Çü, ¼­ºñ½º À¯Çü, Ä¡·á ¿µ¿ª, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â) (2024)

¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

The Drug Discovery Services Market was valued at USD 21.77 billion in 2023, expected to reach USD 24.79 billion in 2024, and is projected to grow at a CAGR of 14.37%, to USD 55.75 billion by 2030.

The drug discovery services market is pivotal in healthcare, focusing on providing comprehensive support through various stages of drug research and development, from target identification to lead optimization. This market is essential due to the increasing demand for innovative therapies to treat chronic and life-threatening diseases, coupled with the need for cost-effective solutions. Its applications span across pharmaceutical and biotechnology companies, universities, and research institutions, with end-use encompassing everything from initial drug screening to preclinical and clinical trial assistance. Market growth is fueled by technological advancements like high-throughput screening, bioinformatics, and machine learning, alongside a surge in R&D expenditure and an increase in drug discovery outsourcing. Opportunities lie in expanding AI integration for predictive modeling and personalized medicine, as well as enhancing the drug development process through collaborative partnerships. To seize these opportunities, companies should focus on fostering strategic alliances with research institutions and tech firms, and invest in cutting-edge technologies. However, the market faces challenges such as stringent regulatory requirements, high initial capital investments, and the complexity of drug development processes. These limitations might impede swift growth. Innovations in areas like CRISPR technology for gene editing, real-time data analytics, and improved virtual screening methods present feasible avenues for business growth. As the nature of the market evolves, there is a visible shift towards more collaborative projects and open-source platforms that encourage shared knowledge and resources. Thus, businesses should aim at enhancing their capacity for innovation by adopting flexible operational frameworks that support iterative learning and adaptation. Companies must also remain agile and responsive to regulatory changes and market demands to succeed in this competitive landscape. By focusing on customer needs and technological integration, organizations can better navigate the market's complexities and drive sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Services Market

The Drug Discovery Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing R&D investments in the pharmaceutical & biopharmaceutical industry
  • Attractive rise in demand for outsourcing analytical testing and clinical trial services
  • Research on rare diseases and orphan drugs
• Market Restraints
  • Expensive drug discovery and development
• Market Opportunities
  • Development in the biologics and focus on drug discovery
  • Potential associated with expiry of patents
• Market Challenges
  • Strict government rules for drug discovery and animal usage

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Services Market

A detailed market share analysis in the Drug Discovery Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Services Market

A strategic analysis of the Drug Discovery Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrodinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Process, market is studied across Candidate Validation, Hit-to-Lead Identification, Lead Optimization, Target Selection, and Target Validation.
• Based on Drug Type, market is studied across Biologics and Small Molecules.
• Based on Service type, market is studied across Biology Services and Chemistry Services.
• Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology.
• Based on End-user, market is studied across Academic Institutes and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
    • 5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
    • 5.1.1.3. Research on rare diseases and orphan drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive drug discovery and development
  • 5.1.3. Opportunities
    • 5.1.3.1. Development in the biologics and focus on drug discovery
    • 5.1.3.2. Potential associated with expiry of patents
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government rules for drug discovery and animal usage
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Discovery Services Market, by Process

• 6.1. Introduction
• 6.2. Candidate Validation
• 6.3. Hit-to-Lead Identification
• 6.4. Lead Optimization
• 6.5. Target Selection
• 6.6. Target Validation

7. Drug Discovery Services Market, by Drug Type

• 7.1. Introduction
• 7.2. Biologics
• 7.3. Small Molecules

8. Drug Discovery Services Market, by Service type

• 8.1. Introduction
• 8.2. Biology Services
• 8.3. Chemistry Services

9. Drug Discovery Services Market, by Therapeutic Area

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Digestive System Diseases
• 9.4. Neurology
• 9.5. Oncology

10. Drug Discovery Services Market, by End-user

• 10.1. Introduction
• 10.2. Academic Institutes
• 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Drug Discovery Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Drug Discovery Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Drug Discovery Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aganitha AI Inc.
• 2. Agilent Technologies, Inc.
• 3. Aurigene Discovery Technologies
• 4. BellBrook Labs
• 5. BioAscent Discovery Ltd.
• 6. Charles River Laboratories International, Inc.
• 7. Domainex Ltd.
• 8. Enzo Life Sciences Inc.
• 9. Eurofins Scientific SE
• 10. Frontage Laboratories, Inc.
• 11. GenScript Biotech Corporation
• 12. Integrated DNA Technologies, Inc.
• 13. IQVIA Inc
• 14. Jubilant Biosys Ltd.
• 15. Labcorp Drug Development
• 16. Merck KGaA
• 17. Piramal Pharma Solutions
• 18. Proteros biostructures GmbH
• 19. Sai Life Sciences Limited
• 20. Schrodinger, Inc.
• 21. Selvita S.A.
• 22. Shanghai ChemPartner
• 23. Shanghai Medicilon, Inc.
• 24. Symeres
• 25. Syngene International Limited
• 26. TCG Lifesciences Pvt. Limited
• 27. Thermo Fisher Scientific Inc.
• 28. UCB S.A.
• 29. Viva Biotech
• 30. Wuxi Apptec